All of the phenotypes that we observed in SIRT6 siRNA-treated HUVECs are equivalent to senescent phenotypes (e.g. reduced capacity of new vessel formation, endothelial dysfunction, and high inflammatory responses) [30]. Here, SIRT6 is linked to endothelial dysfunction.